WO
oncoMASTER operates a precision medicine platform that analyzes genetic and clinical data to provide personalized cancer treatment recommendations. By utilizing a medical twin system powered by big data and AI, the platform predicts treatment outcomes, enhancing patients' chances of survival and quality of life.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- oncoMASTER operates a precision medicine platform that analyzes genetic and clinical data to provide personalized cancer treatment recommendations. By utilizing a medical twin system powered by big data and AI, the platform predicts treatment outcomes, enhancing patients' chances of survival and quality of life.